Julio A. Chirinos of the Perelman School of Medicine is leading a study of fenofibrate, a low-cost cholesterol drug that may be able to fight COVID-19.
https://www.inquirer.com/health/coronavirus/ivermectin-humans-fenofibrate-fluvoxamine-dosage-covid-vaccine-20210826.html Philadelphia Inquirer